OLMA
Olema Pharmaceuticals, Inc. · Healthcare
Director Cyrus Harmon sold $62K of Olema Pharmaceuticals, Inc.
Sold$61,700
$6.17Price
10,000Shares
−1%Stake
What OLMA did after the filing
- The stock from Thu, Jun 8 open, $6.04
- +49.8%
- S&P 500, same days
- +6.9%
Measured over 30 trading days, to the Jul 24 close.
Traded Mon, Jun 5. Filed Wed, Jun 7, 5:30 PM ET, after the close. Returns use the Jun 8 open and the Jul 24 close. Not investment advice.